Impact on insulin sensitivity and insulin resistance after the conversion from tacrolimus twice daily to extended-release tacrolimus once daily in stable renal transplant recipients

Phase 4

Completed

• Conditions: insulin sensitivityinsulin resistance; insulin sensitivity; insulin resistance; tacrolimus; extended release tacrolimus once daily

• Registration Number: TCTR20151005001
• Lead Sponsor: Prajej Ruangkanchanasetr

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2015-09-30
• Study Start: 2015-10-05
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

age more than 18 years old

renal transplantation

stable renal function

Exclusion Criteria

malignancy

critical illness

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
insulin sensitivity and insulin resistance 4, 8, 16 weeks plasma insulin and plasma glucose

Secondary Outcome Measures

Name	Time	Method
the patient satisfaction 16 weeks visual analog scale